http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0059909-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cac4c5c1954282af2893b0287ac7058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a75a01ece2610a9c79c22fd1c7bc66c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2000-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f53735feb9af1453f614be540115318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa77a05e15a12e42a235aae64f31680f
publicationDate 2000-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0059909-A1
titleOfInvention Heterocyclic compounds having affinities for serotonin receptors
abstract Compounds represented the general formula (I) exhibit affinities for various serotonin receptors (such as 5HT-1A, 2, 6, 7, and so on) and are therefore useful as remedies for central nervous system diseases or the like wherein R?1 and R2¿ are each independently hydrogen, lower alkyl, or the like; R?3 and R4¿ are each independently hydrogen, lower alkyl, or the like; or alternatively R?1 and R3¿ may be united to form a single bond; n is 0 or 1; R5 is hydrogen; R6 is hydrogen, hydroxyl, or the like; R7 is hydrogen; R?8 and R9¿ are each independently hydrogen, lower alkylthio, or the like; or alternatively R?7 and R9¿ may be united to form a single bond; R10 is hydrogen, lower alkyl, or the like; R11 is hydrogen, lower alkyl, or the like; and R12 is hydrogen or lower alkyl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1325909-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1325909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10966959-B2
priorityDate 1999-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9528403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0738513-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200

Total number of triples: 37.